Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 500 results in range #1 to #500.
View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)
- Exposure pathway (1 revision)
- Ras (1 revision)
- Functional subunits (1 revision)
- Activity median aerodynamic diameter (1 revision)
- Reference phantom (1 revision)
- Ground-level enhancement (1 revision)
- ICRP Publication 90 (1 revision)
- ICRP Publication 101a (1 revision)
- Size-specific dose estimate (1 revision)
- ICRP Publication 114 (1 revision)
- Specific absorbed fraction (1 revision)
- ICRP Publication 129 (1 revision)
- Surface contamination (1 revision)
- ICRP Publication 143 (1 revision)
- Compartment (environmental) (1 revision)
- ICRP Publication 18 (1 revision)
- Cross section (1 revision)
- Translocation (1 revision)
- Multistage carcinogenesis model (1 revision)
- ICRP Publication 30 (Part 1) (1 revision)
- Deposition (1 revision)
- ICRP Publication 39 (1 revision)
- Digital breast tomosynthesis (1 revision)
- ICRP Publication 53 (1 revision)
- Phantom (1 revision)
- ICRP Publication 68 (1 revision)
- ICRP Publication 82 (1 revision)
- Excess absolute risk (1 revision)
- Rb (1 revision)
- Reference value (1 revision)
- ICRP Publication 91 (1 revision)
- Homologous recombination (1 revision)
- Authorised discharge (1 revision)
- ICRP Publication 101b (1 revision)
- Slice (1 revision)
- ICRP Publication 115 (1 revision)
- ICRP Publication 13 (1 revision)
- Clinical audit (1 revision)
- ICRP Publication 144 (1 revision)
- Threshold level (1 revision)
- ICRP Publication 19 (1 revision)
- ICRP Publication 30 (Part 2) (1 revision)
- ICRP Publication 4 (1 revision)
- Organ at risk (1 revision)
- ICRP Publication 54 (1 revision)
- ICRP Publication 69 (1 revision)
- Principles of protection (1 revision)
- ICRP Publication 83 (1 revision)
- Radiation-induced second cancer (1 revision)
- Reactive oxygen species (1 revision)
- Acute exposure (1 revision)
- Reference worker (1 revision)
- Allometry (1 revision)
- ICRP Publication 92 (1 revision)
- ICRP Publication 102 (1 revision)
- Informed consent (1 revision)
- ICRP Publication 116 (1 revision)
- Spongiosa (1 revision)
- ICRP Publication 130 (1 revision)
- ICRP Publication 145 (1 revision)
- Marrow cellularity (1 revision)
- ICRP Publication 2 (1 revision)
- Multitarget equation (1 revision)
- ICRP Publication 30 (Part 3) (1 revision)
- Derived consideration reference level (1 revision)
- ICRP Publication 40 (1 revision)
- ICRP Publication 55 (1 revision)
- Dose conversion convention (1 revision)
- Pilomatricoma (1 revision)
- ICRP Publication 7 (1 revision)
- ICRP Publication 84 (1 revision)
- Radiation-induced secondary malignancy (1 revision)
- Exclusion (1 revision)
- Radiological attack (1 revision)
- Referrer (1 revision)
- ICRP Publication 93 (1 revision)
- ICRU 4-element tissue (1 revision)
- Biological half-life (1 revision)
- ICRP Publication 117 (1 revision)
- ICRP Publication 131 (1 revision)
- System of radiological protection (1 revision)
- ICRP Publication 146 (1 revision)
- Concentration ratio (1 revision)
- Time-resolved computed tomography (1 revision)
- ICRP Publication 20 (1 revision)
- Mutation component (1 revision)
- ICRP Publication 30 (Part 4) (1 revision)
- Derived investigation level (1 revision)
- Waste management (1 revision)
- Normal tissue complication probability (1 revision)
- ICRP Publication 41 (1 revision)
- Directional dose equivalent (1 revision)
- ICRP Publication 56 (1 revision)
- Dose conversion factor (1 revision)
- ICRP Publication 70 (1 revision)
- Effect modifier (1 revision)
- ICRP Publication 85 (1 revision)
- Endosteum (1 revision)
- Radiological controlled area (1 revision)
- Region (1 revision)
- ICRP Publication 94 (1 revision)
- Human Alimentary Tract Model (1 revision)
- ICRU sphere (1 revision)
- ICRP Publication 104 (1 revision)
- Biomarker (1 revision)
- ICRP Publication 132 (1 revision)
- Clonogenic surviving fraction (1 revision)
- ICRP Publication 147 (1 revision)
- Cone beam computed tomography (1 revision)
- ICRP Publication 21 (1 revision)
- Treatment preparation in radiotherapy (1 revision)
- ICRP Publication 30 (Supplement A to Part 3) (1 revision)
- Derived limit (1 revision)
- Notification value (1 revision)
- ICRP Publication 42 (1 revision)
- Other (systemic) tissues (1 revision)
- ICRP Publication 57 (1 revision)
- ICRP Publication 71 (1 revision)
- ICRP Publication 86 (1 revision)
- Absorption Type (1 revision - redirect page)
- Additional dose (1 revision)
- Regional diagnostic reference levels (1 revision)
- Ambient dose equivalent (1 revision)
- ICRP Publication 95 (1 revision)
- Human Respiratory Tract Model (1 revision)
- Automatic exposure control (1 revision)
- Sealed source (1 revision)
- ICRP Publication 105 (1 revision)
- Solar flare (1 revision)
- ICRP Publication 119 (1 revision)
- ICRP Publication 133 (1 revision)
- Linear dose response (1 revision)
- ICRP Publication 148 (1 revision)
- Mean glandular dose (1 revision)
- ICRP Publication 22 (1 revision)
- Trophic level (1 revision)
- ICRP Publication 30 (Supplement B to Part 3) (1 revision)
- Derived reference level (1 revision)
- Nuclear medicine (1 revision)
- ICRP Publication 43 (1 revision)
- Disposal facility (1 revision)
- ICRP Publication 58 (1 revision)
- Pooled analysis (1 revision)
- ICRP Publication 72 (1 revision)
- ICRP Publication 87 (1 revision)
- Radiation risk (1 revision)
- Additive risk projection model (1 revision)
- Registry (1 revision)
- ICRP Publication 96 (1 revision)
- Secondary radiation (1 revision)
- ICRP Publication 106 (1 revision)
- Intake (1 revision)
- ICRP Publication 12 (1 revision)
- Standard-size adult (1 revision)
- ICRP Publication 134 (1 revision)
- Cobblestone area forming cell assay (1 revision)
- ICRP Publication 149 (1 revision)
- Tissue reaction (1 revision)
- Measured quantity (1 revision)
- ICRP Publication 23 (1 revision)
- DRL quantity (1 revision)
- Tumour suppressor gene (1 revision)
- National DRL (1 revision)
- ICRP Publication 30 (Supplement to Part 1) (1 revision)
- Designated area (1 revision)
- ICRP Publication 44 (1 revision)
- Distribution coefficient (1 revision)
- Oxygen enhancement ratio (1 revision)
- ICRP Publication 59 (1 revision)
- Population risk (1 revision)
- ICRP Publication 73 (1 revision)
- ICRP Publication 88 (1 revision)
- Epigenetic effects (1 revision)
- 1928 Recommendations (1 revision)
- Redox (1 revision)
- Adenoma (1 revision)
- ICRP Publication 97 (1 revision)
- Secretory cells (1 revision)
- ICRP Publication 107 (1 revision)
- Intensity-modulated radiotherapy (1 revision)
- ICRP Publication 120 (1 revision)
- Carers and comforters (1 revision)
- Stem cell (1 revision)
- Kerma approximation (1 revision)
- ICRP Publication 135 (1 revision)
- ICRP Publication 15 (1 revision)
- ICRP Publication 24 (1 revision)
- National radon survey (1 revision)
- ICRP Publication 30 (Supplement to Part 2) (1 revision)
- Detector quantum efficiency (1 revision)
- ICRP Publication 45 (1 revision)
- ICRP Publication 6 (1 revision)
- Potential alpha energy concentration (1 revision)
- ICRP Publication 74 (1 revision)
- ICRP Publication 89 (1 revision)
- Exogenous excretion (1 revision)
- 1931 Recommendations (1 revision)
- Access control (1 revision)
- General Information: Radon (1 revision - redirect page)
- Relative biological effectiveness (1 revision)
- ICRP Publication 98 (1 revision)
- ICRP Publication 108 (1 revision)
- Brachytherapy (1 revision)
- Somatic effect (1 revision)
- ICRP Publication 121 (1 revision)
- Case–control study (1 revision)
- ICRP Publication 136 (1 revision)
- Collective dose (1 revision)
- Targeted effects (1 revision)
- ICRP Publication 150 (1 revision)
- ICRP Publication 25 (1 revision)
- Typical value (1 revision)
- ICRP Publication 31 (1 revision)
- Deterministic effect (1 revision)
- ICRP Publication 46 (1 revision)
- Particle transport (1 revision)
- ICRP Publication 60 (1 revision)
- Dose modifying factor (1 revision)
- ICRP Publication 75 (1 revision)
- ICRP Publication 9 (1 revision)
- 1934 Recommendations (1 revision)
- 1937 Recommendations (1 revision)
- Radon-prone area (1 revision)
- Reference Person (1 revision)
- Adventitious source (1 revision)
- Relative life lost (1 revision)
- Annual intake (1 revision)
- ICRP Publication 99 (1 revision)
- Security screening (1 revision)
- ICRP Publication 109 (1 revision)
- ICRP Publication 122 (1 revision)
- Stochastic effect (1 revision)
- ICRP Publication 137 (1 revision)
- ICRP Publication 151 (1 revision)
- Tolerance dose (1 revision)
- ICRP Publication 26 (1 revision)
- DS86 (1 revision)
- ICRP Publication 32 (1 revision)
- Occupancy factor (1 revision)
- ICRP Publication 47 (1 revision)
- ICRP Publication 61 (1 revision)
- ICRP Publication 76 (1 revision)
- Equilibrium equivalent concentration (1 revision)
- Expanded radiation field (1 revision)
- 1950 Recommendations (1 revision)
- Relative risk (1 revision)
- Ring chromosome (1 revision)
- ICRP Supporting Guidance 2 (1 revision)
- Backscatter factor (1 revision)
- ICRP Publication 10A (1 revision)
- International Commission on Radiological Protection (1 revision)
- ICRP Publication 123 (1 revision)
- Charged-particle equilibrium (1 revision)
- Lag (1 revision)
- ICRP Publication 138 (1 revision)
- Collimation (1 revision)
- Teratocarcinoma (1 revision)
- Low dose (1 revision)
- ICRP Publication 152 (1 revision)
- ICRP Publication 27 (1 revision)
- ICRP Publication 33 (1 revision)
- Detriment-adjusted risk (1 revision)
- ICRP Publication 48 (1 revision)
- Dose-response function (1 revision)
- ICRP Publication 62 (1 revision)
- Potentially lethal damage repair (1 revision)
- ICRP Publication 77 (1 revision)
- Equilibrium factor (1 revision)
- Exposed individuals (1 revision)
- 1954 Recommendations (1 revision)
- Relative survival (1 revision)
- Apoptosis (1 revision)
- ICRP Publication 11 (1 revision)
- Source region (1 revision)
- ICRP Publication 124 (1 revision)
- Late normal tissue responses (1 revision)
- ICRP Publication 139 (1 revision)
- ICRP Publication 153 (1 revision)
- ICRP Publication 28 (1 revision)
- ICRP Publication 34 (1 revision)
- Α/β value (1 revision)
- Oncogene (1 revision)
- ICRP Publication 49 (1 revision)
- ICRP Publication 63 (1 revision)
- ICRP Publication 78 (1 revision)
- Elemental dose (1 revision)
- 1956 Recommendations (1 revision)
- Activation (1 revision)
- ICRP Publication 1 (1 revision)
- Baseline disease rates (1 revision)
- Severe deterministic injury (1 revision)
- ICRP Publication 110 (1 revision)
- Breakpoint cluster region/abelson (1 revision)
- Intervention (1 revision)
- ICRP Publication 125 (1 revision)
- Sublethal damage repair (1 revision)
- ICRP Publication 14 (1 revision)
- Commissioning (1 revision)
- ICRP Publication 154 (1 revision)
- Cosmic radiation (1 revision)
- Transfer of risk (1 revision)
- Molecular imaging (1 revision)
- ICRP Publication 29 (1 revision)
- Noise (1 revision)
- ICRP Publication 35 (1 revision)
- ΓH2AX foci (1 revision)
- Operating management (1 revision)
- ICRP Publication 5 (1 revision)
- Dose-threshold hypothesis (1 revision)
- Pencil beam (1 revision)
- ICRP Publication 64 (1 revision)
- Practice (1 revision)
- ICRP Publication 79 (1 revision)
- 1959 Decisions (1 revision)
- Hereditary effect (1 revision)
- Risk model (1 revision)
- ICRP Publication 10 (1 revision)
- Sheltering (1 revision)
- Induced genomic instability (1 revision)
- ICRP Publication 111 (1 revision)
- ICRP Publication 126 (1 revision)
- Licensee (1 revision)
- ICRP Publication 140 (1 revision)
- Thermodynamic diameter (1 revision)
- Low linear energy transfer radiation (1 revision)
- ICRP Publication 155 (1 revision)
- ICRP Publication 3 (1 revision)
- Nominal risk coefficient (1 revision)
- ICRP Publication 36 (1 revision)
- Dicentric chromosome (1 revision)
- ICRP Publication 50 (1 revision)
- Dose and dose-rate effectiveness factor (1 revision)
- ICRP Publication 65 (1 revision)
- ICRP Publication 8 (1 revision)
- Quality control testing (1 revision)
- Radioactive waste (1 revision)
- Active detection system (1 revision)
- ICRPædia Guide to Radiological Protection in Healthcare (1 revision - redirect page)
- ICRP Publication 100 (1 revision)
- Shielding (1 revision)
- ICRP Publication 112 (1 revision)
- ICRP Publication 127 (1 revision)
- Superposition principle (1 revision)
- Life Span Study (1 revision)
- ICRP Publication 141 (1 revision)
- Thoracic airways (1 revision)
- ICRP Publication 16 (1 revision)
- Multifactorial diseases (1 revision)
- ICRP Publication 30 (1 revision)
- Dental and maxillofacial imaging (1 revision)
- Nominal value (1 revision)
- ICRP Publication 37 (1 revision)
- ICRP Publication 51 (1 revision)
- ICRP Publication 66 (1 revision)
- ICRP Publication 80 (1 revision)
- Exposure index (1 revision)
- AML/eto (1 revision)
- Radon progeny (1 revision)
- Frequent flyer (1 revision)
- Reference parameter value (1 revision)
- Attributable risk (1 revision)
- ICRP Publication 101 (1 revision)
- Best available techniques (1 revision)
- ICRP Publication 113 (1 revision)
- Bronchiolar region (1 revision)
- ICRP Publication 128 (1 revision)
- Supervised area (1 revision)
- ICRP Publication 142 (1 revision)
- Compartment (1 revision)
- Thoron progeny (1 revision)
- ICRP Publication 17 (1 revision)
- Count median diameter (1 revision)
- Transgenerational effect (1 revision)
- ICRP Publication 30 (Index) (1 revision)
- Non-homologous end joining (1 revision)
- ICRP Publication 38 (1 revision)
- Optimisation of protection (1 revision)
- ICRP Publication 52 (1 revision)
- Dose commitment (1 revision)
- ICRP Publication 67 (1 revision)
- Doubling dose (1 revision)
- ICRP Publication 81 (1 revision)
- Quasi-threshold dose (1 revision)
- Evacuation (1 revision)
- Representative organism (non-human biota) (2 revisions)
- ICRPædia Guide to the Basics of Ionising Radiation (2 revisions)
- Beta-minus decay (2 revisions)
- Clearance level (2 revisions)
- Threshold dose for tissue reactions (2 revisions)
- Magnetosphere (2 revisions)
- Dose constraint (2 revisions)
- Early normal tissue responses (2 revisions)
- Radiographer (2 revisions)
- Exposure situation (2 revisions)
- Growth factor (2 revisions)
- Alimentary tract transfer factor (2 revisions)
- Representative person (2 revisions)
- Safety (2 revisions)
- Beta-plus decay (2 revisions)
- Calculating Doses from Intakes of Radionuclides (2 revisions)
- Specific effective energy (2 revisions)
- Limitation of dose (2 revisions)
- Cumulative dose (2 revisions)
- Transmission detection system (2 revisions)
- Multistage tumorigenesis (2 revisions)
- Non-sphericity parameter (2 revisions)
- Dose conversion coefficient (2 revisions)
- Pharynx (2 revisions)
- Edema (2 revisions)
- Excess relative risk (2 revisions)
- Exposure to Radon at Home (2 revisions)
- GATA binding protein 2 (2 revisions)
- Reproductive integrity (2 revisions)
- Hormones (2 revisions)
- Authorization (2 revisions)
- Safety case (2 revisions)
- Slow repair (2 revisions)
- Isotropic geometry (2 revisions)
- Clonogenic cells (2 revisions)
- Lineal energy (2 revisions)
- Thyroid blocking (2 revisions)
- Curie (2 revisions)
- Transparency (2 revisions)
- Waste disposal (2 revisions)
- Non-targeted effects (2 revisions)
- Effect Dose 50 (2 revisions)
- Procedural values (2 revisions)
- Endogeneous excretion (2 revisions)
- Reasonableness (2 revisions)
- Acute radiation syndrome (2 revisions)
- Residual dose (2 revisions)
- Hounsfield unit (2 revisions)
- Authorized limit (2 revisions)
- Safety culture (2 revisions)
- Solar cosmic radiation (2 revisions)
- Inhalability (2 revisions)
- Cardiac arrhythmias (2 revisions)
- Spontaneous fission (2 revisions)
- Itinerant (radiation) worker (2 revisions)
- Clonogenic survival (2 revisions)
- Linear-non-threshold model (2 revisions)
- Cytokines (2 revisions)
- Trapped particles (2 revisions)
- Orphan source (2 revisions)
- Planned exposure situation (2 revisions)
- Progenitor cell (2 revisions)
- Radiation belt (2 revisions - redirect page)
- Adaptive response (2 revisions)
- Alveolar-interstitial region (2 revisions)
- Respiratory protection (2 revisions)
- Autoimmune disease (2 revisions)
- Scintigraphy (2 revisions)
- Solar cycle (2 revisions)
- Inner bremsstrahlung (2 revisions)
- ICRP Publication 118 (2 revisions)
- Cardiac valve diseases (2 revisions)
- Systemic model (2 revisions)
- Linear-quadratic dose response model (2 revisions)
- Time factor (2 revisions)
- Myocardial perfusion (2 revisions)
- What is Radon? (2 revisions)
- Disposal (2 revisions)
- Dose criteria (2 revisions)
- Platelet-derived growth factor (2 revisions)
- Environmental exposure (2 revisions)
- Radiation modifier (2 revisions)
- Exempt waste (2 revisions)
- Radiological protection principles (2 revisions)
- Recovery (cellular or tissue) (2 revisions)
- Retrievability (2 revisions)
- Immune system (2 revisions)
- Institutional control (2 revisions)
- Stakeholder (2 revisions)
- Co-expertise (2 revisions)
- Tachycardia (2 revisions)
- Connective tissue (2 revisions)
- Tissue equivalent material (2 revisions)
- DRL process (2 revisions)
- Myocardial stress test (2 revisions)
- Oversight (2 revisions)
- Projected dose (2 revisions)
- Environmental radiation protection (2 revisions)
- Exemption level (2 revisions)
- Radionuclides of natural origin (2 revisions)
- Radioresponsiveness (2 revisions)
- Recovery responder (2 revisions)
- Gastroschisis (2 revisions)
- Angiogenesis (2 revisions)
- Reversibility (2 revisions)
- Hyperbaric oxygen (2 revisions)
- In vivo radiobioassay (2 revisions)
- Bioturbation (2 revisions)
- Solar particle event (2 revisions)
- Cardioverter-defibrillator (2 revisions)
- Consequential late effects (2 revisions)
- Worker (2 revisions)
- Nuclear track detectors (2 revisions)
- Effective dose equivalent (2 revisions)
- Radiation safety officer (2 revisions)
- Existing exposure situation (2 revisions)
